On Jan. 18, the San Diego Union-Tribune ran a series of three interesting articles examining the biotech sector. One story considers, now that a number of local biotech firms are completing clinical trials, where will they develop their multimillion manufacturing facilities. The other two articles look at selected state and local efforts around the country to support the biotech industry, including Washington, D.C., St. Louis, and Marshfield, WI.
- Switching gears: As clinical trials for biotechs near completion, more companies will focus their efforts and funds on manufacturing: http://www.signonsandiego.com/news/business/biotech/20040118-9999_mz1b18gears.html
- Biotech's lure: Cities and states are spending billions to emulate the success of the San Diego, San Francisco and Boston biotech clusters: http://www.signonsandiego.com/news/business/biotech/20040119-9999-1n18biotech.html
- Three regions chasing biotech: http://www.signonsandiego.com/news/business/biotech/20040119-9999-1n18regions.html
Note: All three of these articles are available for a limited time in the San Diego Union-Tribune online archives. SSTI respects copyright laws and will not republish or archive copyrighted information without first obtaining permission of the original publication or author.